Search Results - "Mockeliūnas, Laurynas"
-
1
Reproducibility in pharmacometrics applied in a phase III trial of BCG-vaccination for COVID-19
Published in Scientific reports (28-09-2023)“…Large clinical trials often generate complex and large datasets which need to be presented frequently throughout the trial for interim analysis or to inform a…”
Get full text
Journal Article -
2
Response of Tradescantia plants to oxidative stress induced by heavy metal pollution of soils from industrial areas
Published in Environmental science and pollution research international (2019)“…Numerous investigations have demonstrated that even soil in which concentrations of individual elements do not exceed permissible limits can cause harmful…”
Get full text
Journal Article -
3
Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial
Published in EClinicalMedicine (01-06-2022)“…BCG vaccination prevents severe childhood tuberculosis (TB) and was introduced in South Africa in the 1950s. It is hypothesised that BCG trains the innate…”
Get full text
Journal Article -
4
Standards for model-based early bactericidal activity analysis and sample size determination in tuberculosis drug development
Published in Frontiers in pharmacology (2023)“…A critical step in tuberculosis (TB) drug development is the Phase 2a early bactericidal activity (EBA) study which informs if a new drug or treatment has…”
Get full text
Journal Article -
5
Derivation and Clinical Utility of Safety Targets for Linezolid-Related Adverse Events in Drug-Resistant Tuberculosis Treatment
Published in Pharmaceuticals (Basel, Switzerland) (01-11-2023)“…Long-term usage of linezolid can result in adverse events such as peripheral neuropathy, anemia and thrombocytopenia. Therapeutic drug monitoring data from 75…”
Get full text
Journal Article -
6
Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modeling
Published in CPT: pharmacometrics and systems pharmacology (01-09-2023)“…Respiratory tract infections (RTIs) are a burden to global health, but their characterization is complicated by the influence of seasonality on incidence and…”
Get full text
Journal Article -
7
Model-Informed Precision Dosing of Linezolid in Patients with Drug-Resistant Tuberculosis
Published in Pharmaceutics (30-03-2022)“…Linezolid is an efficacious medication for the treatment of drug-resistant tuberculosis but has been associated with serious safety issues that can result in…”
Get full text
Journal Article -
8
Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus Pandemic
Published in Vaccines (Basel) (01-03-2024)“…(1) Background: Some individuals are more susceptible to developing respiratory tract infections (RTIs) or coronavirus disease (COVID-19) than others. The aim…”
Get full text
Journal Article -
9
OA-83 Early bactericidal activity of meropenem, ertapenem, amoxicillin/clavulanate and optimized rifampicin in pulmonary tuberculosis
Published in BMJ global health (17-12-2023)“…BackgroundRepurposing established antibiotics for TB has been successful, notably for fluoroquinolones, linezolid, and clofazimine. Meropenem co-administered…”
Get full text
Journal Article